Translational Reserach Institute for Space Health

As a partner to NASA, TRISH funds transformative human health technologies to predict, protect, and preserve astronaut physical and mental wellness during deep space exploration. 

Learn more »


Caltech is a world-renowned science and engineering institute that marshals some of the world's brightest minds and most innovative tools to address fundamental scientific questions and pressing societal challenges.   

Learn more »


Surveying Microbiome Connections to Healthcare with Implications for Long-Duration Human Space Flight

Join this one-day workshop exploring the connection between the microbiome, healthcare and the future of human exploration. How can an interdisciplinary understanding and application of the microbiome enhance astronaut health on a mission to Mars? 

Monday, July 13, 2020 8 am PDT | 11 am EDT Your Desk!

This event is co-hosted by the California Institute of Technology (Caltech) and Translational Research Institute for Space Health (TRISH). TRISH is a consortium led by Baylor College of Medicine with Caltech and MIT. Presentations are 30 minutes long. All sessions are free to attend and open to the public.

Questions? Contact spacehealth-info@bcm.edu.

Sessions and Speakers:

  • 8 a.m. PDT  |  Welcome, Introduction and Context
    Steve Mayo, Ph.D., Caltech and TRISH
       Dorit Donoviel, Ph.D., TRISH
       Sarkis Mazmanian, Ph.D., Caltech
  • 8:15 a.m. PDT  |  Introduction and Overview
       Perspective on the Field and Effects of Radiation on Microbiome

       Rob Knight, Ph.D., University of California San Diego
  • 9 a.m. PDT  |  Immunological Health and Disease
       Gut microbes in Multiple Sclerosis:
       Structural, Functional and Integrative Analysis

       Sergio Baranzini, Ph.D., UCSF
  • 9:30 a.m. PDT  |  BREAK
  • 10 a.m. PDT  |  Behavioral, Mental, Neurological Health and Disease
       (10 a.m.) Gut-Brain Connections to Behaviors in Mice
       Sarkis Mazmanian, Ph.D., Caltech

       (10:30 a.m.) Gut-Brain Connections to Behaviors in Humans
       Emeran Mayer, M.D., Ph.D., UCLA
  • 11 a.m. PDT  |  Diagnostics/Characterization
       (11 a.m.) Microbial Pathways to Metabolite Production
       Michael Fischbach, Ph.D., Stanford

       (11:30 a.m.) Microbiome Sequencing Technologies
       Joe Petrosino, Ph.D., Baylor College of Medicine
  • 12 p.m. PDT  |  BREAK
  • 12:30 p.m. PDT  |  Healthcare Interventions
       (12:30 p.m.) Autism Clinical Trials
       Rosa Krajmalnik-Brown, Ph.D., ASU

       (1 p.m.) Gut Bacteria Human co-Metabolism - Implications in Neuropsychiatric Diseases
       Rima Kaddurah-Daouk, Ph.D., Duke
  • 1:30 p.m. PDT  |  Radiation Effects
       Radiation Effects on Microbiome / Metabolome
       Amrita Cheema, Ph.D., Georgetown
  • 2 p.m. PDT  |  BREAK
  • 2:30 p.m.  PDT |  Investment/Drug Development
       (2:30 p.m.) Investment in Microbiome Space
       Denise Kelly, Ph.D., Seventure

       (3 p.m.) Microbiome in Cancer and COVID-19
       Stephanie Culler, Ph.D., Persephone Biosciences

       (3:30 p.m.) Regulatory Considerations for Microbiome-Based Therapeutics
    Paul Carlson, Ph.D., FDA
  • 4 - 4:05 p.m. PDT  |  Concluding Remarks
    Steve Mayo, Ph.D., Caltech and TRISH   
Download The free eBook